AOD-9604 dose range
The amounts people commonly use, from the low end to the high end, with syringe units, schedule and half-life. The 3 published studies are one click away.
Human trials Metabolic Also called AOD9604, hGH fragment 176-191 (Tyr-modified), Tyr-hGH 177-191
Common use ranges
From published clinic and pharmacy protocols. No drug label exists. Clinic and vendor pages agree well on 250 to 500 mcg once a day, with 300 mcg the most quoted figure. Cycle length varies more.
- Half-life
- Not on the site yet, being checked
- How it is taken
- subcutaneous injection
- How long people use it
- Clinics run 30 day blocks up to 3 in a row, then a month off, or 8 to 16 weeks with check-ins every 4 to 6 weeks.
- Mixing used for the units
- 6 mg vial + 2 mL water. 1 unit on a U-100 insulin syringe = 30 mcg.
Pick your vial size and how much water you add. The units below change to match.
6 mg vial + 2 mL water: 1 unit = 30 mcg
| Tier | Each dose | Syringe units6 mg vial + 2 mL water | How often | Schedule | Vial lastsat this tier |
|---|---|---|---|---|---|
| Starting [1] | 250 mcg | 8.3 units 0.08 mL | once a day | 250 mcg once a day in the morning | about 3 weeks |
| Typical [2] | 300 mcg | 10 units 0.10 mL | once a day | 300 mcg once a day in the morning, before food or exercise | 20 days |
| Higher [3] | 500 mcg | 16.7 units 0.17 mL | once a day | 500 mcg once a day, or split morning and evening | 12 days |
Good to know
- Taken in the morning on an empty stomach.
- The larger human weight loss trial did not beat placebo, and drug development stopped in 2007.
- Joint focused protocols run lower, about 200 to 300 mcg, for 4 to 6 weeks.
- On the WADA banned list.
Sources for these amounts
- Starting: Swolverine, AOD 9604 dosage guide
- Typical: Perfect B Aesthetic Medicine (Doral, FL), AOD 9604 · Swolverine, AOD 9604 dosage guide
- Higher: Swolverine, AOD 9604 dosage guide
How long people use it: Perfect B Aesthetic Medicine (Doral, FL), AOD 9604 · Menscape Clinic (Bangkok), AOD-9604 · Swolverine, AOD 9604 dosage guide
Take the AOD-9604 chart with you
Get a one-page printable chart for AOD-9604, with the syringe units for each vial and water mix. We can also email you when a new AOD-9604 study is published.
This page shows what labels, clinics and users report, and what studies gave. It is not medical advice and not a recommendation for anyone. Many of these compounds are not approved for human use. Check your own medicines and lab work with a licensed clinician before using anything.
See the science: 3 published studies
Amounts given to people in studies
How it was given: By mouth (tablets or capsules), and IV in early trials
No human trial used injection under the skin. Trial details come from a company-linked paper with no PubMed record.
Amounts given to animals in studies
Read this first. The largest trial (502 people, 24 weeks) found no weight loss, and development stopped. All human data come from the maker's own trials, reported in a company-linked journal paper. AOD-9604 was tested in people in several company-run trials, including a larger trial that did not meet its goal. Those trials were not published on PubMed, so they are not in the study table below. The table shows only the published animal studies.
Every study used for this page
Proof grade: Human trials. Tested in randomized human trials. Amounts are quoted as each study reported them. Where the abstract does not state an amount, the row says so.
| Study | Who was studied | Amount given, as reported | Route | How often | How long | What the authors reported |
|---|---|---|---|---|---|---|
| PMID 11146367Ng et al, Horm Res 2000 | Rat, obese Zucker | 500 mcg/kg body weight | By mouth | Once a day | 19 days | Weight gain cut by over half, no harm to insulin sensitivity |
| PMID 11713213Heffernan et al, Endocrinology 2001 | Mouse, obese, and beta-3 receptor knockout mice | Not stated in the abstract | Into the belly | Daily (chronic) | 14 days | Less body weight and body fat in obese mice. No effect in knockout mice |
| PMID 26275694Kwon and Park, Ann Clin Lab Sci 2015 | Rabbit, knee osteoarthritis model (n=32) | 0.25 mg, alone or with 6 mg hyaluronic acid | Into the knee joint | Once a week | 4 weeks (weeks 4 to 7) | Better cartilage scores. Best with hyaluronic acid |
How to read the study numbers
- One study, one group. Each figure is what one team chose for its own participants or animals.
- Route matters. An amount given into a vein (IV) is not the same as the same amount under the skin, in the nose or by mouth.
- Animals are not small people. An animal amount is shown as the study gave it. It is not a human amount.
- Short studies. Many studies ran days or weeks. They do not show what happens over longer use.
Common questions
What amounts of AOD-9604 were used in human studies?
In the studies listed here, people were given from 0.25 mg by mouth once a day for 24 weeks up to 54 mg by mouth once a day for 7 days (IV trials went up to 400 µg/kg one time). The amount used most often was 1 to 30 mg by mouth once a day for 12 weeks. These are what study teams chose for their participants under supervision.
Where do these AOD-9604 numbers come from?
From 3 published studies, each linked to its PubMed or ClinicalTrials.gov record. Every figure was checked against the study abstract or its open full text. Proof grade: Human trials.
Is this a recommendation for how much AOD-9604 to use?
No. This page shows the amounts reported by drug labels, clinics and users, next to what researchers gave in studies. It is not medical advice and not a recommendation for anyone. Talk to a licensed clinician before using any of it.